Decheng Capital Global Life Sciences Fund IV, L.P. - Significant Ownership

Signature - Title
Decheng Capital Global Life Sciences Fund IV, L.P. - By Decheng Capital Management IV (Cayman), LLC, its General Partner, By Xiangmin Cui, Manager
Location
Grand Cayman, Cayman Islands
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Decheng Capital Global Life Sciences Fund IV, L.P..

Significant Ownership of Decheng Capital Global Life Sciences Fund IV, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share 18.3% 3.92M Xiangmin Cui Feb 14, 2025
CGON CG ONCOLOGY, INC. Common stock, $0.0001 par value per share 8.4% $171M 6.37M Xiangmin Cui Dec 31, 2024
UPB Upstream Bio, Inc. Common Stock, par value $0.001 per share 6.1% $29.8M 3.29M Xiangmin Cui Dec 31, 2024

Schedules 13D/G Reported by Decheng Capital Global Life Sciences Fund IV, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.